Trial · NCT02889796
Adverse events792
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 792
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | Filgotinib 200 mg | 26 | 475 | |
| other | Nausea | Gastrointestinal disorders | Filgotinib 100 mg | 16 | 480 | |
| other | Nausea | Gastrointestinal disorders | Adalimumab | 6 | 325 | |
| other | Nausea | Gastrointestinal disorders | Placebo to Filgotinib 200 mg | 4 | 190 | |
| other | Nausea | Gastrointestinal disorders | Placebo to Filgotinib 100 mg | 1 | 191 | |
| other | Nausea | Gastrointestinal disorders | Placebo | 7 | 475 | |
| other | Nasopharyngitis | Infections and infestations | Filgotinib 200 mg | 43 | 475 | |
| other | Nasopharyngitis | Infections and infestations | Filgotinib 100 mg | 48 | 480 | |
| other | Nasopharyngitis | Infections and infestations | Adalimumab | 24 | 325 | |
| other | Nasopharyngitis | Infections and infestations | Placebo to Filgotinib 200 mg | 7 | 190 | |
| other | Nasopharyngitis | Infections and infestations | Placebo to Filgotinib 100 mg | 6 | 191 | |
| other | Nasopharyngitis | Infections and infestations | Placebo | 25 | 475 | |
| other | Upper respiratory tract infection | Infections and infestations | Filgotinib 200 mg | 41 | 475 | |
| other | Upper respiratory tract infection | Infections and infestations | Filgotinib 100 mg | 49 | 480 | |
| other | Upper respiratory tract infection | Infections and infestations | Adalimumab | 21 | 325 | |
| other | Upper respiratory tract infection | Infections and infestations | Placebo to Filgotinib 200 mg | 8 | 190 | |
| other | Upper respiratory tract infection | Infections and infestations | Placebo to Filgotinib 100 mg | 6 | 191 | |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 14 | 475 | |
| other | Urinary tract infection | Infections and infestations | Filgotinib 200 mg | 18 | 475 | |
| other | Urinary tract infection | Infections and infestations | Filgotinib 100 mg | 19 | 480 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02889796/events